Wednesday 21 August at 2pm
Nearly three-quarters of people with multiple sclerosis (MS) experience spasticity and over half experience chronic pain. These debilitating symptoms can severely impact daily life and overall wellbeing. However, both have symptoms have been shown to have positive responses to cannabis-based treatments.
So, for our next information session, MS-UK is excited to announce our collaboration with Releaf, the UK’s leading all-in-one medical cannabis service, to provide safe and legal access to cannabis-based options.
Join us for our information session on Wednesday the 21 August at 2pm, with Dr David Tang, Clinical Director of Releaf and Graham Woodward, Releaf’s Chief Operating Officer and Specialist Adviser to the CQC, to find out more.
In the session we will hear from the Releaf team, sharing the remarkable success they have seen in treating individuals with MS-related symptoms including severe muscle spasms, joint pain and poor sleep. We will also discover how they safely and seamlessly, incorporate medical cannabis into MS treatment plans.
You can find more information on this topic of cannabis by viewing our Choices booklet, Cannabis and MS. The booklet provides an introduction to cannabis including its use and research behind its benefits, plus the products that are available.
To find out more about medical cannabis including how it is prescribed and its benefits for people with MS, please see our blog.
Graham Woodward (Chief Operating Officer) has a wealth of expertise as a trained psychiatric nurse and nearly two decades of experience in the NHS, Graham has worked in A and E departments, crisis teams and as a Community Psychiatric Nurse (CPN). He has also served as the medical director for a large charity with 800 staff, responsible for delivering services in Oxford, Hackney, and Tower Hamlets.
Additionally, Graham established Myaccess clinics and was awarded outstanding leadership at Leva Clinic. He joined Releaf in November 2023. Graham’s background includes pivotal roles as a Clinical Director and Quality Assurance Director, and he has experience as a CQC Specialist Advisor. He is dedicated to maintaining the highest standards in our operational processes.
Dr David Tang (Acting Medical Director) graduated from Guy’s, King’s, and St Thomas’ Medical School in 2007 and has served as a Consultant in Emergency Medicine since 2021. Throughout his career, he has gained valuable experience working alongside the military and various elite sports teams.
Driven by a commitment to assist patients who have had trouble finding the right support through the healthcare system and pharmaceutical options, Dr Tang began his transition into medical cannabis prescribing. He specialises in prescribing for patients with musculoskeletal and chronic conditions that have not responded well to standard treatments.
As the Medical Director at Releaf, Dr Tang is dedicated to leading the charge in medical innovation, aiming to provide safe, effective treatment options for those in real need.
To join this session, please login or register in our Portal area. The session is free to join if you have a monthly or year subscription. You do not need a subscription to join, as you can register and provide a donation for the class. The suggested amount for the class is £5. If you unable to make a donation, please contact us to see how you can access the online classes.
If you would like to know more or you are having trouble registering, please contact us at register@ms-uk.org.
